AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. WINT
  4. [8-K] Windtree Therapeutics, Inc. Reports Material Event

[8-K] Windtree Therapeutics, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock WINT logo
Windtree Therapeutics Inc

NASDAQ:WINT

WINT Rankings

#10168 Ranked by Market Cap
N/A Ranked by Dividends

WINT Latest News

Aug 11, 2025
Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025
Aug 5, 2025
Windtree Announces Istaroxime Phase 2 Interim Analysis in SCAI Stage C Cardiogenic Shock Patients
Jul 29, 2025
Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption
Jul 24, 2025
Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy
Jul 22, 2025
Kraken and Windtree Therapeutics Announce Strategic Partnership for BNB Custody, Trading, and OTC Services

WINT Latest SEC Filings

Aug 8, 2025
[DEF 14A] Windtree Therapeutics, Inc. Definitive Proxy Statement
Aug 8, 2025
[8-K] Windtree Therapeutics, Inc. Reports Material Event
Aug 5, 2025
[Form 3] Windtree Therapeutics, Inc. Initial Statement of Beneficial Ownership
Aug 5, 2025
[8-K] Windtree Therapeutics, Inc. Reports Material Event
Aug 4, 2025
[8-K] Windtree Therapeutics, Inc. Reports Material Event

WINT Stock Data

6.68M
28.66M
0%
0.43%
22.48%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WARRINGTON